KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $314.0 million.

  • Bausch Health Companies' Free Cash Flow fell 598.8% to $314.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 359.51%. This contributed to the annual value of $1.3 billion for FY2024, which is 5422.28% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Free Cash Flow is $314.0 million, which was down 598.8% from $190.0 million recorded in Q2 2025.
  • Bausch Health Companies' 5-year Free Cash Flow high stood at $501.0 million for Q3 2021, and its period low was -$1.3 billion during Q3 2022.
  • In the last 5 years, Bausch Health Companies' Free Cash Flow had a median value of $240.0 million in 2023 and averaged $152.0 million.
  • Within the past 5 years, the most significant YoY rise in Bausch Health Companies' Free Cash Flow was 85740.74% (2022), while the steepest drop was 36287.43% (2022).
  • Over the past 5 years, Bausch Health Companies' Free Cash Flow (Quarter) stood at -$54.0 million in 2021, then surged by 857.41% to $409.0 million in 2022, then dropped by 28.61% to $292.0 million in 2023, then surged by 69.52% to $495.0 million in 2024, then tumbled by 36.57% to $314.0 million in 2025.
  • Its last three reported values are $314.0 million in Q3 2025, $190.0 million for Q2 2025, and $96.0 million during Q1 2025.